Gatimore OZ (30 ml) is a Fixed-Dose Combination (FDC) Drug Brand being manufactured and marketed by Moraceae Pharmaceuticals (P) Ltd.. This medicine is combination of more than one active ingredient or substance within a single pharmaceutical form type. The main active ingredients or salts in this drug are Ornidazole, Gatifloxacin. This drug comes in the form of Syrup. The general packing available for this medicine consists of 30 ml and is priced at Rs 48.5 (arround $0.679 US Dollar)
Generic (Salt) Combination :
(Ornidazole+ Gatifloxacin)
Pharma Company :
Moraceae Pharmaceuticals (P) Ltd.
Brand Label :
Gatimore OZ (30 ml)
Preparation Type :
Syrup
Single Dose :
5 ml
Composition (Fixed-Dose Combination) :
Ornidazole-125 mg
Gatifloxacin-50 mg
Pack Size/Qty/Vol :
30 ml
Price Unit :
Rs 8.08 INR (arround $0.11312 US Dollar)
Price Pack :
Rs 48.5 INR (arround $0.679 US Dollar)
Drug details for Gatimore OZ (30 ml)
Usage: Why is this medication prescribed?
The main active ingredients or salts in Gatimore OZ (30 ml) are :
Ornidazole-125 mg
Gatifloxacin-50 mg
Ornidazole Indication (Prescribed for or used as): Intestinal and hepatic amoebiasis. Giardiasis. Trichomoniasis. Bacterial vaginosis. Anaerobic infections.
For more details on Ornidazole, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Ornidazole..
Gatifloxacin Indication (Prescribed for or used as):
For more details on Gatifloxacin, its Indication, Prescription, Usage, Dosage, Precaution, Side Effects etc, please check : Gatifloxacin..
Gatimore OZ (30 ml) Drug Brands Substitutes with similar Fixed-Dose Combination (FDC) :
There are 2 Fixed-Dose Combination (FDC) Drug Brands listed here as Substitutes for Gatimore OZ (30 ml), which have same Fixed-Dose Combination of active substances or ingredients (i.e. Ornidazole-125 mg Gatifloxacin-50 mg). Please note that one can request a doctor or pharmacist to substitute a FDC Brand Version of the prescribed FDC drug brand, if any. Fixed-Dose Combination Drugs are being increasingly used due to the benefit of the combined effects of active ingredients given together. However, it is necessary to investigate the possible benefits in the clinical situation against possible disadvantages for each fixed combination drug and for each dose of the fixed combination drug. Potential advantages of fixed combination drugs may also include the counteracting by one ingredient of an adverse reaction produced by another one, and simplification of therapy, leading to improved compliance.